The role of glucocorticoids, catecholamines and endocannabinoids in the development of traumatic memories and posttraumatic stress symptoms in survivors of critical illness - PubMed
Review
The role of glucocorticoids, catecholamines and endocannabinoids in the development of traumatic memories and posttraumatic stress symptoms in survivors of critical illness
Daniela Hauer et al. Neurobiol Learn Mem. 2014 Jul.
Abstract
Critically ill patients are at an increased risk for traumatic memories and post-traumatic stress disorder (PTSD). Memories of one or more traumatic events play an important part in the symptom pattern of PTSD. Studies in long-term survivors of intensive care unit (ICU) treatment demonstrated a clear and vivid recall of traumatic experiences and the incidence and intensity of PTSD symptoms increased with the number of traumatic memories present. Preclinical evidence has clearly shown that the consolidation and retrieval of traumatic memories is regulated by an interaction between the noradrenergic, the glucocorticoid and the endocannabinoid system. Critically ill patients in the ICU frequently require treatment with adrenenergic or glucocorticoid drugs and often receive sedative medications; among them propofol is known to influence endocannabinoid signaling. Critical illness could therefore represent a useful model for investigating adrenergic, glucocorticoid as well as endocannabinoid effects on traumatic memory and PTSD development in stressed humans. The endocannabinoid system is an important regulator of HPA-axis activity during stress, an effect which has also been demonstrated in humans. Likewise, a single nucleotide polymorphism (SNP) of the glucocorticoid receptor (GR) gene (the BclI-SNP), which enhances the sensitivity of the glucocorticoid receptors to cortisol and possibly HPA-axis feedback function, was associated with enhanced emotional memory performance in healthy volunteers. The presence of the BclI-SNP increased the risk for traumatic memories and PTSD symptoms in patients after ICU therapy and was linked to lower basal cortisol levels. A number of small studies have demonstrated that the administration of cortisol to critically ill or injured patients results in a significant reduction of PTSD symptoms after recovery without influencing the number of traumatic memories. These glucocorticoid effects can possibly be explained by a cortisol-induced temporary impairment in traumatic memory retrieval which has previously been demonstrated in both rats and humans. The hypothesis that stress doses of glucocorticoids or the pharmacologic manipulation of glucocorticoid-endocannabinoid interaction during traumatic memory consolidation and retrieval could be useful for prophylaxis and treatment of PTSD after critical illness should be tested in larger controlled studies.
Keywords: Adrenergic drugs; Endocannabinoids; Glucocorticoids; Intensive care therapy; Post-traumatic stress disorder; Traumatic memory.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Can posttraumatic stress disorder be prevented with glucocorticoids?
Schelling G, Roozendaal B, De Quervain DJ. Schelling G, et al. Ann N Y Acad Sci. 2004 Dec;1032:158-66. doi: 10.1196/annals.1314.013. Ann N Y Acad Sci. 2004. PMID: 15677403
-
Post-traumatic stress disorder in somatic disease: lessons from critically ill patients.
Schelling G. Schelling G. Prog Brain Res. 2008;167:229-37. doi: 10.1016/S0079-6123(07)67016-2. Prog Brain Res. 2008. PMID: 18037018 Review.
-
Schelling G. Schelling G. Neurobiol Learn Mem. 2002 Nov;78(3):596-609. doi: 10.1006/nlme.2002.4083. Neurobiol Learn Mem. 2002. PMID: 12559838
-
Hauer D, Weis F, Krauseneck T, Vogeser M, Schelling G, Roozendaal B. Hauer D, et al. Brain Res. 2009 Oct 13;1293:114-20. doi: 10.1016/j.brainres.2009.04.014. Epub 2009 Apr 17. Brain Res. 2009. PMID: 19376097
-
Glucocorticoid-induced reduction of traumatic memories: implications for the treatment of PTSD.
de Quervain DJ. de Quervain DJ. Prog Brain Res. 2008;167:239-47. doi: 10.1016/S0079-6123(07)67017-4. Prog Brain Res. 2008. PMID: 18037019 Review.
Cited by
-
Sex and gender differences in intensive care medicine.
Merdji H, Long MT, Ostermann M, Herridge M, Myatra SN, De Rosa S, Metaxa V, Kotfis K, Robba C, De Jong A, Helms J, Gebhard CE. Merdji H, et al. Intensive Care Med. 2023 Oct;49(10):1155-1167. doi: 10.1007/s00134-023-07194-6. Epub 2023 Sep 7. Intensive Care Med. 2023. PMID: 37676504 Free PMC article. Review.
-
Lohr JB, Chang H, Sexton M, Palmer BW. Lohr JB, et al. CNS Spectr. 2020 Dec;25(6):743-749. doi: 10.1017/S1092852919001093. Epub 2019 Jul 15. CNS Spectr. 2020. PMID: 31303187 Free PMC article. Review.
-
Ross JA, Van Bockstaele EJ. Ross JA, et al. Eur J Neurosci. 2020 Jul;52(1):2429-2465. doi: 10.1111/ejn.14714. Epub 2020 Apr 20. Eur J Neurosci. 2020. PMID: 32125035 Free PMC article. Review.
-
Mura G, Cossu G, Migliaccio GM, Atzori C, Nardi AE, Machado S, Carta MG. Mura G, et al. Clin Pract Epidemiol Ment Health. 2014 Jun 13;10:67-72. doi: 10.2174/1745017901410010067. eCollection 2014. Clin Pract Epidemiol Ment Health. 2014. PMID: 25006344 Free PMC article.
-
Karakahya RH. Karakahya RH. Cureus. 2021 Nov 26;13(11):e19915. doi: 10.7759/cureus.19915. eCollection 2021 Nov. Cureus. 2021. PMID: 34966612 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical